Chiara Bravetti

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophy.

Modifying disease registries to address the evolving field in rare diseases: the iSMAc/ITASMAc experience in spinal muscular atrophy.

Journal: Frontiers in neurology

Published: March 18, 2026

Management of spinal muscular atrophy: nursing clinical commentary and best practices update.

Management of spinal muscular atrophy: nursing clinical commentary and best practices update.

Journal: Journal of pediatric nursing

Published: January 07, 2026

Italian validation of the SMA independence scale-upper limb module.

Italian validation of the SMA independence scale-upper limb module.

Journal: European journal of pediatrics

Published: March 03, 2025

Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study.

Myostatin Levels in SMA Following Disease-Modifying Treatments: A Multi-Center Study.

Journal: Annals of clinical and translational neurology

Published: February 20, 2025

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen.

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen.

Journal: European journal of neurology

Published: February 05, 2025

Ultrasound-assisted and landmark-based nusinersen delivery in spinal muscular atrophy adults: A retrospective analysis.

Ultrasound-assisted and landmark-based nusinersen delivery in spinal muscular atrophy adults: A retrospective analysis.

Journal: Australasian journal of ultrasound in medicine

Published: December 30, 2024

Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data.

Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 24, 2024

Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016.

Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016.

Journal: EClinicalMedicine

Published: September 09, 2024

Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study.

Prognostic factors for tube feeding in type I SMA patients treated with disease-modifying therapies: a cohort study.

Journal: European journal of pediatrics

Published: May 29, 2024

High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes.

High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes.

Journal: Molecular neurobiology

Published: February 21, 2024

Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?

Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?

Journal: European journal of pediatrics

Published: January 17, 2024

Caregivers' Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study.

Caregivers' Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study.

Journal: Journal of clinical medicine

Published: May 11, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026